BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31440846)

  • 1. Assessing the risk of osteoporotic fractures: the Ecuadorian FRAX model.
    Lopez Gavilanez E; Johansson H; McCloskey E; Harvey NC; Segale Bajana A; Marriott Blum D; Navarro Grijalva M; Diaz Curiel M; Kanis JA
    Arch Osteoporos; 2019 Aug; 14(1):93. PubMed ID: 31440846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of hip fracture in Brazil and the development of a FRAX model.
    Zerbini CA; Szejnfeld VL; Abergaria BH; McCloskey EV; Johansson H; Kanis JA
    Arch Osteoporos; 2015; 10():224. PubMed ID: 26303038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures.
    Lalmohamed A; Welsing PM; Lems WF; Jacobs JW; Kanis JA; Johansson H; De Boer A; De Vries F
    Osteoporos Int; 2012 Mar; 23(3):861-9. PubMed ID: 22120910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of hip fracture in Romania and the development of a Romanian FRAX model.
    Grigorie D; Sucaliuc A; Johansson H; Kanis JA; McCloskey E
    Calcif Tissue Int; 2013 May; 92(5):429-36. PubMed ID: 23334302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and application of FRAX in the management of osteoporosis in Ireland.
    McGowan B; Kanis JA; Johansson H; Silke C; Whelan B
    Arch Osteoporos; 2013; 8():146. PubMed ID: 23982943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of hip fracture in Belarus: development of a country-specific FRAX model and its comparison to neighboring country models.
    Ramanau H; Chernyanin I; Rudenka E; Lesnyak O; Zakroyeva A; Bilezikian JP; Johansson H; Harvey NC; McCloskey EV; Kanis JA
    Arch Osteoporos; 2018 Apr; 13(1):42. PubMed ID: 29666948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of fractures in Armenia: development of a country-specific FRAX model and comparison to its surrogate.
    Lesnyak O; Sahakyan S; Zakroyeva A; Bilezikian JP; Hutchings N; Babalyan V; Galstyan R; Lebedev A; Johansson H; Harvey NC; McCloskey E; Kanis JA
    Arch Osteoporos; 2017 Nov; 12(1):98. PubMed ID: 29116417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of a FRAX revision for the USA.
    Kanis JA; Johansson H; Oden A; Dawson-Hughes B; Melton LJ; McCloskey EV
    Osteoporos Int; 2010 Jan; 21(1):35-40. PubMed ID: 19705047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.
    Leslie WD; Lix LM; Langsetmo L; Berger C; Goltzman D; Hanley DA; Adachi JD; Johansson H; Oden A; McCloskey E; Kanis JA
    Osteoporos Int; 2011 Mar; 22(3):817-27. PubMed ID: 21161509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updated fracture incidence rates for the Italian version of FRAX®.
    Piscitelli P; Chitano G; Johannson H; Brandi ML; Kanis JA; Black DM
    Osteoporos Int; 2013 Mar; 24(3):859-66. PubMed ID: 22638710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women.
    Leslie WD; Brennan SL; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
    Arch Osteoporos; 2013; 8():145. PubMed ID: 23929269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of hip fracture in Barranquilla, Colombia, and the development of a Colombian FRAX model.
    Jaller-Raad JJ; Jaller-Char JJ; Lechuga-Ortiz JA; Navarro-Lechuga E; Johansson H; Kanis JA
    Calcif Tissue Int; 2013 Jul; 93(1):15-22. PubMed ID: 23471427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of osteoporotic fracture in Kazakhstan and development of a country specific FRAX model.
    Issayeva S; Lesnyak O; Zakroyeva A; Issayeva B; Dilmanova D; Johansson H; Liu E; Lorentzon M; Harvey NC; McCloskey E; Kanis JA
    Arch Osteoporos; 2020 Feb; 15(1):30. PubMed ID: 32108270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of osteoporotic fracture in Moldova and development of a country-specific FRAX model.
    Zakroyeva A; Lesnyak O; Cazac V; Groppa L; Russu E; Chislari L; Rotaru L; Johansson H; Harvey NC; McCloskey E; Lorentzon M; Kanis JA
    Arch Osteoporos; 2020 Jan; 15(1):13. PubMed ID: 31993755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.
    Fraser LA; Langsetmo L; Berger C; Ioannidis G; Goltzman D; Adachi JD; Papaioannou A; Josse R; Kovacs CS; Olszynski WP; Towheed T; Hanley DA; Kaiser SM; Prior J; Jamal S; Kreiger N; Brown JP; Johansson H; Oden A; McCloskey E; Kanis JA; Leslie WD;
    Osteoporos Int; 2011 Mar; 22(3):829-37. PubMed ID: 21161508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale of the Spanish FRAX model in decision-making for predicting osteoporotic fractures: an update of FRIDEX cohort of Spanish women.
    Azagra R; Zwart M; Encabo G; Aguyé A; Martin-Sánchez JC; Puchol-Ruiz N; Gabriel-Escoda P; Ortiz-Alinque S; Gené E; Iglesias M; Moriña D; Diaz-Herrera MA; Utzet M; Manresa JM;
    BMC Musculoskelet Disord; 2016 Jun; 17():262. PubMed ID: 27317560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A surrogate FRAX model for the Kyrgyz Republic.
    Lesnyak O; Zakroyeva A; Lobanchenko O; Johansson H; Liu E; Lorentzon M; Harvey NC; McCloskey E; Kanis JA
    Arch Osteoporos; 2020 May; 15(1):68. PubMed ID: 32377964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of hip fractures in Bulgaria: development of a country-specific FRAX model.
    Kirilova E; Johansson H; Kirilov N; Vladeva S; Petranova T; Kolarov Z; Liu E; Lorentzon M; Vandenput L; Harvey NC; McCloskey E; Kanis JA
    Arch Osteoporos; 2020 Feb; 15(1):28. PubMed ID: 32108268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Epidemiology of Hip and Major Osteoporotic Fractures in a Dutch Population of Community-Dwelling Elderly: Implications for the Dutch FRAX® Algorithm.
    Klop C; Welsing PM; Leufkens HG; Elders PJ; Overbeek JA; van den Bergh JP; Bijlsma JW; de Vries F
    PLoS One; 2015; 10(12):e0143800. PubMed ID: 26633011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FRAX® probabilities and risk of major osteoporotic fracture in France.
    Couris CM; Chapurlat RD; Kanis JA; Johansson H; Burlet N; Delmas PD; Schott AM
    Osteoporos Int; 2012 Sep; 23(9):2321-7. PubMed ID: 22179418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.